Guest blogger and genetic counselor Andi Ybarra, MS, CGC tells us all about it:
We know that colorectal cancer is the second leading cause of cancer-related deaths in the United States. We also know that when it’s caught early, it’s curable up to 95% of the time. So why aren’t we catching it early? It turns out that at least 60% of Americans age 50 and older have never been screened for colorectal cancer, even though the American Cancer Society (ACS) recommends lifelong screening, including a colonoscopy every 10 years.
In the last few weeks, results of a federal study showed that a virtual colonoscopy, an X-ray of the colon, is similar in its effectiveness to traditional colonoscopies at screening for colon cancer. This is great news—no one looks forward to turning 50 so they can begin having colonoscopies. However, virtual colonoscopy still requires people to clean out their bowels, and exposes them to considerable radiation. So, while it’s less invasive than a colonoscopy, for many it can be inconvenient and anxiety-inducing.
At DNA Direct, we think people need better choices. We’ve found that some people are embarrassed or unwilling to undergo invasive screening—and some would rather go without. Updated ACS guidelines in March of 2008 added both virtual colonoscopy and stool DNA testing to the recommended arsenal of screenings for colon cancer. We thought about how we could help people who know the importance of screening and early detection, but who can’t or won’t undergo colonoscopy.
DNA Direct will now offer the ColoSure™ colon cancer screening assay, a state-of-the-art, safe, simple, and convenient at-home test, through our website. A study published in the September 2008 American Journal of Gastroenterology shows that ColoSure is superior to first-generation stool tests, demonstrating both higher specificity (83%) and sensitivity (77%) with simple collection – in your home, at your convenience. Who knew we’d be so excited about a test that requires collection in our bathrooms?
DNA Direct delivers test results via our web-enabled reports, complete with next steps, a physician’s letter and a full lab report. We think ColoSure is a great example of genetic testing that makes a real difference in healthcare decisions today—allowing people who might be anxious or fearful about invasive screenings to take steps to detect colorectal cancer in its earliest stages.
ColoSure is meant for people at average-risk for colorectal cancer and is among the most sensitive, non-invasive colorectal cancer screening tools available to detect colorectal cancer at any stage at any location in the colon. Are you over 50? Well, what are you waiting for?
This entry was posted
on Wednesday, October 1st, 2008 at 10:26 am and is filed under Colon Cancer.
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.